JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: PF-05231023 is novel and potent, long-acting FGF21-receptor agonist being developed as a potential treatment for T2DM. PF-05231023 is a FGF21 mimetic that decreases body weight and improves lipid profile in non-human primates and in type 2 diabetic subjects.
References: Diabetes. 2018 May; 67(5):974-985.; Horm Mol Biol Clin Investig. 2017 May 19; 30(2).
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!